Investors
- Board of Directors
- Board Meeting
- AGM Notice
- EGM Notice
- Closure Of Trading Window
- Related Party Transactions
- Share Holding Patterns
- Quarterly Results
- Annual Report
- Annual Return
- Secretarial Compliance
- Disclosure U/r 30
- Voting Results
- Newspaper Publications
- Insider Trading Code
- Investors-2
Mail to: companysec@indswift.com[Email id of designated official for the purpose of grievance redressal]
| UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 31ST DECEMBER, 2005 |
|||||
|---|---|---|---|---|---|
| (RS. IN LACS) | |||||
| PARTICULARS | Quarter ended 31.12.2005 (Unaudited) |
Quarter ended 31.12.2004 (Unaudited) |
Nine Months Ended 31.12.2005 (Unaudited) |
Nine Months Ended 31.12.2004 (Unaudited) |
Year Ended 31.03.2005 (Audited) |
| INCOME FROM OPERATIONS | 7686.50 | 6400.12 | 22339.71 | 18169.41 | 24812.52 |
| OTHER INCOMES | |||||
| PROFIT ON SALE OF SHARES | 0.00 | 1050.68 | 0.00 | 1050.68 | 1050.68 |
| OTHER INCOME | 170.23 | 13.71 | 272.79 | 115.40 | 493.13 |
| TOTAL INCOME | 7856.73 | 7464.51 | 22612.50 | 19335.49 | 26356.33 |
| TOTAL EXPENDITURE | 6864.92 | 5677.43 | 20006.45 | 16157.40 | 22310.54 |
| DECREASE IN STOCK IN TRADE | 357.52 | 1830.34 | 82.22 | 1668.13 | 1177.08 |
| CONSUMPTION OF RAW MATERIAL | 5389.65 | 2996.41 | 16737.01 | 12004.28 | 17646.71 |
| STAFF COST | 258.99 | 190.48 | 713.72 | 552.50 | 784.89 |
| OTHER EXPENSES | 858.76 | 660.20 | 2473.50 | 1932.49 | 2701.86 |
| INTEREST | 262.29 | 155.51 | 667.72 | 457.32 | 765.53 |
| DEPRECIATION | 36.40 | 26.20 | 103.10 | 89.15 | 133.66 |
| PROFIT BEFORE TAX | 693.12 | 1605.37 | 1835.23 | 2631.62 | 3146.60 |
| PROVISION FOR TAX | 46.81 | 41.60 | 137.64 | 118.57 | 144.47 |
| PROVISION FOR DEFERRED TAX | 25.18 | 111.25 | 56.07 | 170.64 | 402.84 |
| NET PROFIT | 621.13 | 1452.52 | 1641.52 | 2342.41 | 2599.29 |
| PAID UP SHARE CAPITAL (FACE VALUE OF RS. 2/-PER SHARE)* | *743.57 | 611.57 | *743.57 | 611.57 | 727.57 |
| RESERVES (EXCLUDING REVALUATION RESERVES) | --------- | ---------- | ---------- | ----------- | 10251.51 |
| E. P. S. (RS.) NOT ANNUALISED (PAR VALUE RS. 2/-PER SHARE) * | *1.67 | 23.75 | *4.42 | 38.30 | 41.85 |
| NON-PROMOTERS SHAREHOLDING | |||||
| NO. OF SHARES | 24291445 | 3961295 | 24291445 | 3961295 | 4758295.00 |
| % OF TOTAL HOLDING | 65.34 | 64.77 | 65.34 | 64.77 | 65.40 |
| Notes:- | |||||
| * Par value of Rs. 2/-per share. | |||||
1. The figures of the Net Profit of the quarter and nine months ended 31.12.2005 and 31.12.2004 are not comparable as the profit during 31.12.2004 included other income of Rs. 1050.68 Lacs from sales of shares. 2. During the quarter under review, the income from operations increased by 20% and the net profit from operations increased by 55% over the corresponding figures during same period previous year. 3. The Company launched over 10 new products during the last quarter which included a unique combination of the quinoline-derivative, anti-diarrhieal plus antibacterial drug which was launched for the first time in India after completing the successful clinical trials. 4. The company has launched a health awareness programme covering 110 educational institutions. 5. The Company had no pending complaints as on beginning of the quarter under review. There were 6 complaints received during the quarter, which all were disposed off and as such, there are no pending complaints.; 6. Previous year figures have been regrouped and/or rearranged wherever considered necessary. 7. The Company is exclusively in the Pharmaceutical business segment. 8. The above results were reviewed by the audit committee and taken on record by the Board of Directors at its meeting held on 30th January, 2006. |
|||||
| By Order of the Board | |||||
| Dated: 30.01.2006 | (Dr. Gopal Munjal) | ||||
| Place: Chandigarh | Chairman | ||||